Atopic dermatitis (eczema)

Making sense of eczema

Eczemaletters header image 2

The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.

February 8th, 2008 · No Comments

Related Articles

The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.

Dermatology. 2007;215 Suppl 1:18-26

Authors: Meurer M, Lubbe J, Kapp A, Schneider D

In approximately 60% of patients atopic eczema starts in early childhood and persists throughout adolescence. The inadequate treatment of adult patients with recurrent flaring atopic eczema is associated with poor symptom control and diminished quality of life. The prolonged continuous use of topical corticosteroids is not advocated because of the risk of local and systemic adverse events. Pimecrolimus cream 1% (Elidel) is an alternative to topical corticosteroids, particularly for delicate skin, e.g. face and other sensitive skin areas, because it has no atrophogenic potential. The results from clinical trials in adult patients demonstrate that intermittent treatment with pimecrolimus relieves the acute symptoms of atopic eczema and improves disease control and quality of life in the long term.

PMID: 18174690 [PubMed - in process]

→ Discuss article in Forum Tags: Research

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.